Ridgewood Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.48M |
| 2 |
ALPS Medical Breakthroughs ETF
SBIO
|
+$851K |
| 3 |
RB Global
RBA
|
+$600K |
| 4 |
Baxter International
BAX
|
+$535K |
| 5 |
International Flavors & Fragrances
IFF
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$955K |
| 2 |
Cardinal Health
CAH
|
+$806K |
| 3 |
Deere & Co
DE
|
+$621K |
| 4 |
Kimberly-Clark
KMB
|
+$594K |
| 5 |
Goldman Sachs
GS
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.03% |
| 2 | Healthcare | 10.58% |
| 3 | Technology | 8.88% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Banco Santander
SAN
$210B
| $12 | ﹤0.01% |
+3
| New | +$11 |
|
827
V2X
VVX
$2.65B
| – | – |
0
| – | – |
|
828
LENSAR
LNSR
$74.2M
| $8 | ﹤0.01% |
+3
| New | +$9 |
|
|
HEXO
829
DELISTED
HEXO Corp. Common Shares
HEXO
| $7 | ﹤0.01% |
+5
| New | +$7 |
|
830
CALL
Sabre
SABR
$835M
| – | – |
-15,000
| Closed | -$92.7K |
|
831
CALL
AT&T
T
$163B
| – | – |
-10,000
| Closed | -$184K |
|
|
SCNX
832
Scienture Holdings
SCNX
$15.4M
| – | – |
-4,126
| Closed | -$24.9K |
|
|
SRAX
833
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
| – | – |
-181,663
| Closed | -$278K |
|
Similar funds
Ridgewood Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Ridgewood Investments held 833 positions worth $163M, up 16% from $141M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ridgewood Investments deployed $22.4M of net new capital in Q1 2023, opening 632 new positions and adding to 56 existing holdings. Its largest new stake was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $955K trimmed.
- Ridgewood Investments's largest Q1 2023 buy was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
- Ridgewood Investments added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $3.48M increase.
- Ridgewood Investments's biggest Q1 2023 reduction was Gilead Sciences, cutting an estimated $955K.
- Ridgewood Investments fully exited SRAX, Inc. Class A Common Stock in Q1 2023, selling an estimated $278K.
- Ridgewood Investments's ten largest holdings make up 24% of its $163M portfolio in Q1 2023.
- Ridgewood Investments opened 632 new positions and closed 4 in Q1 2023.
- Ridgewood Investments's portfolio value rose 16% quarter-over-quarter to $163M.
Based on Ridgewood Investments's 13F filing for Q1 2023, filed 25 Apr 2023.